Zhangzhou Pientzehuang Pharmaceutical | 600436 - Ebitda


Zhangzhou Pientzehuang Pharmaceutical reported CNY882.7M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -9.69M 12.21M Dec/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Dianthus Therapeutics USD -46.46M 6.27M Mar/2026
Ionis Pharmaceuticals USD -200.02M 42.89M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
Jiangsu Hengrui CNY 2.3B 678.46M Dec/2025
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Moderna USD -790M 582M Dec/2025
Revvity USD 272.91M 24M Mar/2026
Sh Fosun Pharma CNY 1.57B 128.23M Dec/2025
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Viatris USD 1.05B 46.4M Mar/2026
WuXi AppTec CNY 5.64B 3.31B Mar/2026
Xeris Pharmaceuticals USD 12.33M 12.76M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026